The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non‐small cell lung cancer patients with epidermal growth factor receptor mutation-Reference-Cited by-同舟云学术

The efficacy and possible mechanisms of immune checkpoint inhibitors in treating non‐small cell lung cancer patients with epidermal growth factor receptor mutation

Published:2021-10-26 Issue:12 Volume:41 Page:1314-1330
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Ma Lin¹²,Diao Bowen³,Huang Zhaoqin⁴,Wang Bin¹,Yu Jinming¹²,Meng Xiangjiao¹²^ORCID

Affiliation:

1. Cheeloo College of Medicine Shandong University Jinan 250117 Shandong P. R. China

2. Department of Radiation Oncology Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences Jinan 250117 Shandong P. R. China

3. Department of Gynecology, First Affiliated Hospital, School of Medicine Shihezi University Shihezi 832061 Xinjiang P. R. China

4. Department of Radiology Shandong Provincial Hospital Affiliated to Shandong First Medical University Jinan 250117 Shandong P. R. China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12229

Reference106 articles.